Tag: GLP-1s

The Weight of Perception: Obesity and Workplace Bias

As a country and as a society overall, we’ve always thought about and had discussions about “weight loss” and “diets”. However, in recent times, the spotlight on obesity and its treatment has intensified. Some of that can be attributed to the fascination with Ozempic. After all, the New Yorker named 2023 the “Year of Ozempic” […]

Balancing the Scales: What the Rise of GLP-1s Means for Employers Today

Glucagon-like peptide-1 agonists (GLP-1s) are a class of medications originally intended for the treatment of type 2 diabetes and obesity. However, in the last year, they’ve become known for their impact on the polarizing topic of weight loss. With GLP-1s, patients can successfully lose weight without having to do activities traditionally associated with losing weight, […]